Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Sarcopenia and Diabetes Mellitus
Authors not listed
Dionyssiotis, Yannis, M.D. · 2018
Abstract
The association of diabetes mellitus type 2 (T2DM) with sarcopenia has not been adequately investigated. Sarcopenia is characterized by progressive and generalized loss of skeletal muscle mass which may affect performance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2018). Sarcopenia and Diabetes Mellitus. <em>Dionyssiotis, Yannis, M.D.</em>. https://clinicaltrials.gov/study/NCT04407819
Vancouver
Anonymous. Sarcopenia and Diabetes Mellitus. Dionyssiotis, Yannis, M.D.. 2018.
BibTeX
@misc{anon2018Sarcop,
title = {Sarcopenia and Diabetes Mellitus},
author = {Anonymous},
journal = {Dionyssiotis, Yannis, M.D.},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Wiener Medizinische Wochenschrift 2018
Citation only
Sarcopenia
Clinics in Geriatric Medicine 2010
Citation only
Sarcopenia
Clinics in Geriatric Medicine 2017
Citation only
Sarcopenia
Nature Reviews Disease Primers 2024
Citation only
Sarcopenia
The Lancet 2019
Citation only
Sarcopenia
Joint Bone Spine 2018
Open access · OA